ASX
Amplia Therapeutics Limited
ATX:ASX•Healthcare
Sensitive ASX Announcement
Inhibition of FAK by AMP945 in Phase 1 Clinical Trial
Published: 17/11/21, 08:25am (AEST)•2 pages